Dramatic study results point to the potential for a steroid-sparing option for patients with the underrecognized multiorgan ...

Shares of Amgen Inc. (NASDAQ:AMGN – Get Free Report) have been assigned a consensus recommendation of “Hold” from the ...

The stock has a market capitalization of $152.45 billion, a P/E ratio of 36.31, a P/E/G ratio of 2.69 and a beta of 0.60. Amgen (NASDAQ:AMGN – Get Free Report ... BLINCYTO for the treatment of ...